Celcuity Ownership | Who Owns Celcuity?
Celcuity Ownership Summary
Celcuity is owned by 16.83% institutional investors, 13.96% insiders, and 69.21% retail investors. Morgan stanley is the largest institutional shareholder, holding 8.44% of CELC shares. Eventide Healthcare & Life Sciences I is the top mutual fund, with 3.41% of its assets in Celcuity shares.
CELC Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Celcuity | 16.83% | 13.96% | 69.21% |
Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Morgan stanley | 2.84M | 8.44% | $46.44M |
Bvf inc/il | 3.47M | 8.10% | $45.37M |
Baker bros. advisors lp | 2.68M | 6.26% | $35.06M |
Soleus capital management | 2.57M | 5.99% | $33.58M |
Perceptive advisors | 2.36M | 5.52% | $30.92M |
Blackrock funding, inc. /de | 2.18M | 5.09% | $28.52M |
Blackrock | 1.46M | 4.34% | $23.91M |
Vanguard group | 1.65M | 3.86% | $21.62M |
Eventide asset management | 1.27M | 2.96% | $16.57M |
Samlyn capital | 1.25M | 2.92% | $16.38M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Saturn v capital management | 1.06M | 5.45% | $13.92M |
Cunning capital partners, lp | 52.47K | 2.90% | $4.84M |
Soleus capital management | 2.57M | 2.11% | $33.58M |
Bvf inc/il | 3.47M | 1.54% | $45.37M |
Nea management company | 1.25M | 0.92% | $16.36M |
Vivo capital | 610.50K | 0.90% | $7.99M |
Perceptive advisors | 2.36M | 0.85% | $30.92M |
Commodore capital lp | 400.00K | 0.38% | $5.24M |
Baker bros. advisors lp | 2.68M | 0.37% | $35.06M |
Braidwell lp | 884.31K | 0.34% | $11.58M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Soleus capital management | 2.57M | 2.11% | 1.32M |
Baker bros. advisors lp | 2.68M | 0.37% | 803.58K |
Janus henderson group | 648.12K | 0.00% | 648.12K |
Morgan stanley | 2.84M | 0.00% | 486.12K |
Blackrock funding, inc. /de | 2.18M | 0.00% | 368.62K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Commodore capital lp | 400.00K | 0.38% | -1.12M |
Vr adviser | - | - | -970.00K |
Exoduspoint capital management, lp | - | - | -691.45K |
Pfm health sciences, lp | 158.75K | 0.13% | -551.51K |
Adage capital partners gp | - | - | -350.32K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Janus henderson group | 648.12K | 0.00% | 648.12K | $8.47M |
Pfizer | 349.41K | 0.18% | 349.41K | $4.57M |
Candriam s.c.a. | 263.59K | 0.02% | 263.59K | $3.45M |
Gsa capital partners llp | 19.23K | 0.02% | 19.23K | $252.00K |
Intech investment management | 16.65K | 0.00% | 16.65K | $217.94K |
Sold Out
Holder | Change |
---|---|
National bank of canada /fi/ | -1.00 |
Nelson, van denburg & campbell wealth management group | -3.00 |
Capital performance advisors llp | -10.00 |
Srs capital advisors | -104.00 |
Venturi wealth management | -413.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 56 | -48.15% | 7,202,654 | -76.01% | 16 | 0.34% | 33 | -49.23% | 10 | -44.44% |
Sep 30, 2024 | 108 | 16.13% | 30,022,227 | 2.25% | 70 | 0.92% | 65 | 10.17% | 18 | -10.00% |
Jun 30, 2024 | 92 | 13.58% | 29,360,224 | 32.68% | 87 | 1.00% | 59 | 22.92% | 20 | 11.11% |
Mar 31, 2024 | 81 | 32.79% | 22,129,121 | 38.67% | 93 | 1.80% | 48 | 54.84% | 18 | 28.57% |
Dec 31, 2023 | 61 | 5.17% | 15,958,102 | 3.90% | 72 | 1.47% | 31 | 29.17% | 14 | - |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Eventide Healthcare & Life Sciences I | 1.27M | 3.41% | -269.35K |
Vanguard US Total Market Shares ETF | 1.00M | 2.66% | - |
Vanguard Total Stock Mkt Idx Inv | 984.56K | 2.65% | - |
iShares Russell 2000 ETF | 849.60K | 2.25% | -7.37K |
Vanguard Institutional Extnd Mkt Idx Tr | 396.06K | 1.07% | 10.68K |
SPDR® S&P Biotech ETF | 327.79K | 0.88% | -2.00K |
Artisan Non-U.S. Small-Mid Growth Comp | 326.57K | 0.88% | 56.67K |
Artisan International Small-Mid Investor | 326.57K | 0.88% | 56.67K |
Columbia Small Cap Value I | 319.68K | 0.86% | 22.90K |
Columbia Small Cap Value I A | 317.98K | 0.86% | -1.70K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Oct 23, 2024 | Buller Richard E | - | Sell | $5.69K |
Aug 23, 2024 | Buller Richard E | - | Sell | $5.93K |
Jun 21, 2024 | Buller Richard E | - | Sell | $5.49K |
Apr 24, 2024 | Buller Richard E | - | Sell | $5.97K |
Feb 21, 2024 | Buller Richard E | - | Sell | $4.95K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | - | - |
2024 Q4 | - | 1 |
2024 Q3 | - | 1 |
2024 Q2 | - | 2 |
2024 Q1 | - | 1 |
CELC Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools